Amplifine PRP

Amplifine HD PRP Tubes

PLATELET RICH PLASMA

A PRP platform that delivers ideal platelet concentrations

Our Suneva Amplifine PRP system is 510(k) cleared for the safe and rapid preparation of PRP at the patient point of care.

A SYSTEM TO CAPTURE HIGH CONCENTRATIONS OF PLATELET RICH PLASMA (PRP)

Amplifine PRP Infographic
Amplifine PRP Infographic

*Mean platelet concentration by removing ~10 mL of Platelet Poor Plasma (PPP).

Multiple gel tube sizes offer greater flexibility

Amplifine PRP Gel Tubes 15mL
  • 6 minute spin
  • 13 mL blood draw
  • 6.5 mL PRP Yield
  • 1500 G-force RCF
Amplifine PRP Gel Tubes 30mL
  • 10 minute spin
  • 30 mL blood draw
  • 15.6 mL PRP Yield
  • 1600 G-force RCF

A complete PRP platform designed with busy clinical practices in mind

Amplifine PRP Gel Tubes

Amplifine PRP Gel Tubes

  • Contains Suneva’s proprietary gel separator to capture high concentrations of PRP
  • 15 mL gel tubes available in both single- and 3-tube packs
  • 30 mL gel tubes available in both 3- and 10-tube packs
Amplifine PRP Blood Draw Kits

Blood Draw Kits

  • Offered as a convenience for your busy practices
  • Available in 10-kit packs
Custom Amplifine PRP Centrifuge

Custom Amplifine PRP Centrifuge

  • Designed for quick processing time
  • Holds both 15 mL and 30 mL gel tubes

BECOME
AN AMPLIFINE
PRP PROVIDER

JOIN TODAY


References: 1. Amplifine HD PRP Gel Tube (15 and 30 mL) [Instructions for Use]. San Diego, CA: Suneva Medical, Inc.; 2020. 2. PRP Optimization Testing, Data on file. Suneva Medical, Inc.

REGULATORY STATUS: FDA-cleared 510(k) Class II medical device. Amplifine HD PRP Gel Separator Tubes are designed to be used for the safe and rapid preparation of autologous platelet rich plasma (PRP) from a small sample of peripheral blood at the patient point of care. The PRP is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics.

SM3243 REV08

Important Safety Information

Bellafill®
Bellafill® is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. Patients who have had a positive reaction to the Bellafill® Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring should not receive Bellafill®. The safety of Bellafill® for use during pregnancy, breastfeeding, or in patients under 21 has not been established. You may experience temporary swelling, redness, pain, bruising, lumps/bumps, itching, and discoloration at the treatment site. These side effects are usually transient and typically resolve within 1–7 days. You may experience lumps/bumps/papules that may occur more than one month after injection and that may persist. Less common side effects include rash and itching more than 48 hours after treatment, persistent swelling or redness, lumps/bumps, acne, and increased sensitivity at treatment sites. Infrequently, granulomas may occur and may be treated by your licensed physician provider. Be sure to call your licensed provider immediately if you notice any unusual skin reactions around the treatment area. Based on the 5-year Post-Approval Study on nasolabial folds with 1,008 patients, long-term safety of Bellafill® for up to 5 years has been established.

PUREGRAFT
This product is certified as a medical device in the European Union under the Medical Device Directive 93/42/EEC by SGS CE0120, exclusively for the indication of autologous fat transfer. Other non-medical uses ascribed to this device such as aesthetic body contouring are not within the scope of CE certification, and users should be aware product performance and/or safety has not been evaluated by SGS for those purposes.

Suneva Medical HD PRP
REGULATORY STATUS: FDA-cleared 510(k) Class II medical device. Healeon HD PRP is designed to be used for the safe and rapid preparation of autologous platelet-rich-plasma (PRP) from a small sample of peripheral blood at the patient point of care. The PRP is mixed with autograft and/orallograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK170136

Silhouette Instalift
Silhouette lnstaLift® is indicated for use in mid-face suspension surgery to temporarily fixate the cheek sub-dermis in an elevated position.

IMPORTANT SAFETY CONSIDERATIONS
The Silhouette InstaLift device should not be used in patients with any known allergy or foreign body sensitivities to plastic/ biomaterial or in situations where internal fixation is otherwise contraindicated, (e.g. infection.) The device should also not be used in patients appearing to have very thin soft tissue of the face in which the implant may be visible or palpable.

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction, pain (which may be temporary or persistent in nature), swelling and edema, transient hematoma or bruising and transient rippling or dimple formation. For further safety or product information, please consult your physician.

For more safety information, please consult with your physician and the patient labeling that can be found by visiting our website www.bellafill.com.
Toll-free call (U.S. & Canada): 844-Bellafill (844-235-5234).
Local calls: 858-550-9999. International calls: ++ 858-550-9999.